[Dermatomyositis and polymyositis].
In this review article the author stresses the fact that it is difficult to find a classification which fulfils all clinical, morphological and pathogenetic criteria and that is not advisable to separate the late onset myopathies of M. Shy from the group of polymyositis. Treatment with high doses of corticosteroids is useful in most cases, whereas in individual patients immunosuppressive agents may be tried.
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D001219:Aspartate Aminotransferases / Q000097:blood; D001799:Blood Sedimentation; D002277:Carcinoma / Q000150:complications; D002648:Child; D002675:Child, Preschool; D003095:Collagen Diseases / Q000150:complications; D003401:Creatine / Q000652:urine; D003402:Creatine Kinase / Q000097:blood; D003882:Dermatomyositis / Q000145:classification / Q000188:drug therapy; D004576:Electromyography; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged; D009220:Myositis / Q000145:classification / Q000188:drug therapy; D012712:Serum Globulins
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D012712:Serum Globulins; D001219:Aspartate Aminotransferases; D003402:Creatine Kinase; D003401:Creatine
Dermatomyositis and Polymyositis